PLGA-PEG-NH2
PLGA-PEG-NH2 is a material to synthesis nanomicelles. PLGA-PEG-NH2 nanomicelle is an efficient delivery system of Irinotecan for targeted colorectal cancer and hepatocellular carcinoma[1].
Product Specifications
UNSPSC
12352211
Target
Biochemical Assay Reagents
Type
Oligonucleotides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/plga-peg-nh2.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic) |Ethanol : < 1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
OC(C)C(OCC(NCCOCCN)=O)=O.[x].[y].[n]
References & Citations
[1]Emami J, et al. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan. Pharm Dev Technol. 2018;23 (1) :41-54.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC403070 20 µg
GLEPP1 (PTPRO) (NM_030667) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC682729-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/2729R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP14647PU-N 400 µL
TGF beta Receptor I (TGFBR1) (Center) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details